Keyphrases
Diabetic Patients
100%
Lower Limb Amputation
100%
Statin Use
100%
Non-elderly
100%
Amputation Risk
100%
Hazard Ratio
45%
Statins
36%
Confidence Interval
36%
Treatment Failure
36%
Non-statins
18%
Veterans Affairs Healthcare System
18%
Failure Hazard
18%
Cholesterol-lowering Medication
18%
United States Department of Veterans Affairs
18%
Cholesterol-lowering Agents
18%
Unanswered Questions
9%
Peripheral Arterial Disease
9%
Large-scale Clinical Trial
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Nave
9%
High Risk
9%
Mellitus Diabetes
9%
Peripheral Neuropathy
9%
Patients with Diabetes
9%
Major Risk Factors
9%
Statin Therapy
9%
Demographic Factors
9%
Body Mass Index
9%
Cholesterol
9%
Coronary Artery Disease
9%
Significant Benefit
9%
Foot Ulcer
9%
Beneficial Effects
9%
Type I Diabetes
9%
Systolic Blood Pressure
9%
Diastolic Blood Pressure
9%
Hemoglobin A1c (HbA1c)
9%
Pleiotropic Effects
9%
Exposure Time
9%
High Potency
9%
Trial Experience
9%
Low Risk
9%
Retrospective Cohort
9%
Cholesterol-lowering
9%
Non-traumatic
9%
Type 1 and Type 2 Diabetes Mellitus
9%
Diabetic Medications
9%
Hazard Risk
9%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Diabetes Mellitus
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
40%
Hypocholesterolemic Agent
40%
Non Insulin Dependent Diabetes Mellitus
40%
Cohort Study
20%
Clinical Trial
20%
Diabetic Agent
20%
Peripheral Occlusive Artery Disease
20%
Foot Ulcer
20%
Insulin Dependent Diabetes Mellitus
20%
Hemoglobin A1c
20%
Neuropathy
20%
Ischemic Heart Disease
20%